Additionally, systemic hyperinsulinemia and reduced hepatic insulin clearance—potentially due to decreased expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) because of hepatic IR—further promote hepatic lipogenesis (52). The gene discussed is CEACAM1; the disease is Hyperinsulinemia.